China Pharma Holdings (CPHI) Tax Provisions (2010 - 2018)
China Pharma Holdings (CPHI) posted Tax Provisions of $1921.0 for Q4 2018, up 101.2% on a QoQ basis from -$160485.0 in Q3 2018, and down 93.71% year-over-year from $30525.0 in Q4 2017.
China Pharma Holdings (CPHI) Tax Provisions (2010 - 2018) Analysis & Trends
China Pharma Holdings' Tax Provisions history runs 9 years deep, the most recent figure standing at $1921.0 for Q4 2018.
- Quarterly Tax Provisions fell 93.71% year-over-year to $1921.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$109989.0 (down 189.69% YoY) and the FY2025 annual result came in at -$796890.0, up 32.7% from the prior year.
- Tax Provisions was $1921.0 for Q4 2018 at China Pharma Holdings, up from -$160485.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $134800.0 in Q4 2014 and bottomed at -$2.3 million in Q4 2016.
- A 5-year average of -$105707.2 and a median of $11360.5 in 2016 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2016 — Tax Provisions sank 2034.37% — and 2017, when it jumped 232.88%.
- China Pharma Holdings' Tax Provisions stood at $134800.0 in 2014, then fell by 12.42% to $118057.0 in 2015, then sank by 2034.37% to -$2.3 million in 2016, then surged by 101.34% to $30525.0 in 2017, then slumped by 93.71% to $1921.0 in 2018.
- Business Quant data shows CPHI's Tax Provisions at $1921.0 in Q4 2018, -$160485.0 in Q3 2018, and $22590.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1,921.00 |
| Sep 30, 2018 | -160,485.00 |
| Jun 30, 2018 | 22,590.00 |
| Mar 31, 2018 | 25,985.00 |
| Dec 31, 2017 | 30,525.00 |
| Sep 30, 2017 | 31,198.00 |
| Jun 30, 2017 | 30,574.00 |
| Mar 31, 2017 | 30,334.00 |
| Dec 31, 2016 | -2.28 Mn |
| Sep 30, 2016 | 20,800.00 |
| Jun 30, 2016 | 21,416.00 |
| Mar 31, 2016 | -22,828.00 |
| Dec 31, 2015 | 118,057.00 |
| Sep 30, 2015 | -18,906.00 |
| Jun 30, 2015 | -19,428.00 |
| Mar 31, 2015 | -19,284.00 |
| Dec 31, 2014 | 134,800.00 |
| Sep 30, 2014 | -19,215.00 |
| Jun 30, 2014 | -19,196.00 |
| Mar 31, 2014 | -19,347.00 |